1 / 28

Bioanalytical Method Validation Review: Common Problems

Bioanalytical Method Validation Review: Common Problems. Olutosin Remi Idowu, Ph.D. Division of Human Food Safety Office of New Animal Drug Evaluation FDA Center for Veterinary Medicine ( olutosin.idowu@fda.hhs.gov ). Hierarchy of Analytical Methodology. Technique

verna
Download Presentation

Bioanalytical Method Validation Review: Common Problems

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Bioanalytical Method Validation Review: Common Problems Olutosin Remi Idowu, Ph.D. Division of Human Food Safety Office of New Animal Drug Evaluation FDA Center for Veterinary Medicine (olutosin.idowu@fda.hhs.gov)

  2. Hierarchy of Analytical Methodology Technique Scientific principle useful for providing information on analyte concentration Example: HPLC Method Distinct adaptation of a technique for a given analytical purpose Example: HPLC analysis of a drug in cat serum.

  3. Hierarchy of Analytical Methodology • Procedure • Written directions necessary to perform a method • Example: Direction on extraction of sample • Protocol (Method SOP) • Set of definitive directions that must be followed without exception, if the analytical results are to be accepted for a given purpose. • Based of method validation • Has GLP implications although method validation is not required to be GLP-compliant

  4. Method Validation Purposes of Method Validation • Establish the performance characteristics of the method • Demonstrate that an analytical method is acceptable for its intended purpose • Establish a method protocol or SOP

  5. Method Validation Purposes of Method Validation • Ensure appropriate method application • Provide objective basis for evaluating the data obtained when using the method • An often ignored aspect of method validation during later method application

  6. Validation Parameters Recommended in FDA Guidance No. 145 Data Quality-Related Parameters • Preparation and storage stability of standard solutions • Method limit of detection (LOD), lower limit of quantitation (LLOQ) and upper limit of quantitation (ULOQ) • Calibration curve linearity • Method specificity/selectivity

  7. Validation Parameters Recommended in FDA Guidance No. 145 Data Quality-Related Parameters • Intra- and inter-assay precision and accuracy • Method recovery • Ability to dilute samples originally above the method upper limit of quantitation (ULOQ) - Parallelism • System suitability

  8. Validation Parameters Recommended in FDA Guidance No. 145 Sample/Analyte Integrity-Related Parameters 9. Freeze-thaw stability of the analyte in the matrix (plasma or serum) 10. Short-term room temperature stability of the analyte in the matrix

  9. Validation Parameters Recommended in FDA Guidance No. 145 Sample/Analyte Integrity-Related Parameters 11. Long-term storage stability of the analyte in the matrix 12. Post-preparative storage stability of the analyte in extracts – short- and long- term

  10. MethodValidation and Evaluation of Incurred Sample Data Data Quality-Related Parameters • LOD is required to evaluate reliability of chosen LLOQ • LOD, LLOQ, ULOQ required to evaluate the validity/reliability of results from analysis of incurred samples Sample/Analyte Integrity-Related Parameters • Stability data required to provide assurance on the integrity of standard solutions and incurred samples during method application

  11. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews General Problems • Failure to validate method before application to analysis of incurred samples • GLP implication: Code of Federal Regulations 21 CFR 58.33 require study to follow an approved protocol – including method SOP

  12. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews General Problems • Failure to demonstrate one or more of the validation parameters • Failure to submit all raw and calculated validation data and chromatograms to CVM

  13. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews • Specific problems • 1. Preparation and storage stability of standard solutions • Failure to document the calculation of the quantity of compound (salt) required to prepare a stock solution having a given concentration of the active ingredient • Incorrect calculation of the quantity of compound (salt) required to prepare stock solution having a given concentration of the active ingredient

  14. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews Specific problems 1. Preparation and storage stability of standard solutions (cont.) • Wrong molecular mass of salt or active ingredient • Failure to correct for purity when necessary • Incorrect dilution or concentration scheme usually due to failure to account for the total volume of solution obtained following stock solution dilution

  15. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews 2. Calibration curve • Incorrect regression parameters • Application of weighted regression without statistical justification • Extrapolating below or above the validated dynamic range of the calibration curve during application of the method to incurred samples

  16. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews 3. Stability of Analyte in Incurred Sample • Failure to demonstrate the stability of incurred samples from the time of sample collection to the time of last analysis of the samples

  17. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews 4. Raw and Calculated Data • No Table of raw data used to calculate the validation parameters • No Validation chromatograms or illegible chromatograms • Good Laboratory Practice (GLP) regulations 21 CFR 58.130 require the collection of legible data

  18. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews 5. LC-MS • Failure to account for the fragment ion being measured • Incorrect ion fragmentation

  19. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews Method Application Problems 1. Data acceptance criteria • Not included in the SOP • Criteria more forgiving than Guidance No. 145 recommendations

  20. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews Method application problems 2. Re-assay of incurred samples • Decision to re-assay samples not determined by the pre-set QC-based data acceptance criteria • Use of results that were initially rejected

  21. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews Method application problems 3. Calculation of concentration of incurred samples • Extrapolating below or above the validated dynamic range of calibration curve

  22. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews Method application problems 4. Chromatograms • Poor chromatography of incurred samples as compared to method validation samples • No system suitability data that are needed to access chromatographic peak purity

  23. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews Method application problems 5. Analyst Recertification • Failure to demonstrate analyst recertification with method if extended period has passed between method development and use for bioequivalence study

  24. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews Avoid Bioanalytical Method Review Problems • Submit validation protocol and proposed method SOP to CVM for review and comment • Validate the parameters recommended by FDA GFI No. 145

  25. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews Avoid Bioanalytical Method Review Problems • Submit validation data (raw and calculated, and all chromatograms) to CVM for review before application of the method to analysis of incurred samples • Be aware that analytical method SOP will be incorporated into the protocol for a GLP bioequivalence study.

  26. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews Avoid Bioanalytical Method Review SOP Problems • Ensure that method SOP follows a scientifically acceptable format that includes all required sections • Each section of the method SOP should contain the information relevant to that section, without reference to other SOPs that are not subject to FDA/CVM review for the BEQ study

  27. CommonlyEncountered Problems During Bioanalytical Validation/Data Reviews Avoid Bioanalytical Method Review SOP Problems • Avoid setting Data Acceptance and Sample Re-analysis Criteria that may introduce bias • Use only quantitative Data Acceptance Criteria • Report data as numbers, not statements such as “<LLOQ”

  28. THANK YOU!

More Related